With the debate surrounding the efficacy and safety of UV-C technology, individuals need which generation the product is. Infection Control Today® continues to feature special coverage on UV-C technology.
Although the germicidal effects of ultraviolet light were first discovered in 1877, the debate over the efficacy of ultraviolet-C light (UV-C) technology continues in the healthcare industry today. Also, some researchers have published studies that show it’s safe, while others aren’t, and the question boils down to which company’s technology works and what doesn’t. Does the company use its own research, done by an independent research firm, or does the company use competitor data? What generation of UV-C technology did the researchers use?
Second of 2 parts in this exclusive Infection Control Today® (ICT®) interviewed Gunner Lyslo, founder and CEO of Surfacide, to continue his discussion of where the industry is headed and what questions healthcare organizations, schools, businesses and others should ask when looking for UVC technology to keep employees and visitors safe.
Although UV-C has been shown to be effective against SARS-CoV-2, some people are still reluctant to consider UV-C technology. Lyslo counters that second-generation technologies, such as Surfacide, have proven the technology works.
“This is a very important technology [and] Disinfection method. If used in an evidence-based manner, with proper usage instructions, it will have a huge impact on the interests of all end-users and all individuals entering these spaces. [This is true] Will it be a hospital and which hospitals will remain primary [Surfacide], because that’s where you’re dealing with immunocompromised patient populations, and where you’re dealing with environmental services teams are frontline health care workers who face a lot of workplace stress. “
The first part of the Lyslo interview is here.